Yvan Devaux
Latest publications
Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.
- Cardiovascular Research Unit
2021 Nov. J Mol Cell Cardiol.160:56-70. Epub 2021 May 13.
Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: A Position Paper from the EU-CardioRNA COST Action CA17129.
- Cardiovascular Research Unit
2021 Oct. Cardiovasc Res. Online ahead of print.
Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson's disease?
- Cardiovascular Research Unit
2021 Oct. Neural Regen Res.16(10):2017-2018.
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action.
- Cardiovascular Research Unit
2021 Sep. Basic Res Cardiol.116(1):52.
Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.
- Cardiovascular Research Unit
2021 Jul. Cardiovasc Res.117(8):1823-1840.
N(6)-methyladenine in eukaryotic DNA: tissue distribution, early embryo development and neuronal toxicity.
- Immune Endocrine and Epigenetics
- Quantitative Biology Unit
- Cardiovascular Research Unit
2021 May. Front Genet.12:657171.
Dissecting the transcriptome in cardiovascular disease.
- Cardiovascular Research Unit
2021 Mar. Cardiovasc Res. Online ahead of print.
Epigenetics in cardiovascular disease. 1st ed. (Book)
- Cardiovascular Research Unit
2021 Mar. Elsevier Science, 2021. 498 p. (Translational Epigenetics, Vol.24). ISBN 978-0-12-822258-4 (Paperback ISBN); 978-0-12-822259-1 (eBook ISBN).
Conclusions and perspectives: The present and future of epigenetics in cardiovascular disease. In Epigenetics in cardiovascular disease. 1st ed. (Book Chapter)
- Cardiovascular Research Unit
2021 Mar. Devaux Y and Robinson E, eds. Elsevier Science, 2021. p.459-461. (Translational Epigenetics, Vol.24). ISBN 978-0-12-822258-4 (Paperback ISBN); 978-0-12-822259-1 (eBook ISBN).
The Long Noncoding RNA Landscape of Cardiac Regeneration in Zebrafish.
- Cardiovascular Research Unit
2021 Mar. Can J Cardiol.37(3):484-492. Epub 2020 Aug 22.
CDR132L: another brick in the wall towards the use of miRNAs to treat cardiovascular disease.
- Cardiovascular Research Unit
2021 Jan. Eur Heart J.42(2):202-204.
Increased miR-142 levels in plasma and atherosclerotic plaques from peripheral artery disease patients with post-surgery cardiovascular events.
- Cardiovascular Research Unit
2020 Dec. Int J Mol Sci.21(24).
Regulation of microRNAs in high-fat diet induced hyperlipidemic hamsters.
- Cardiovascular Research Unit
2020 Nov. Sci Rep.10(1):20549.
Joining European scientific forces to face pandemics.
- Cardiovascular Research Unit
2020 Nov. Trends Microbiol.29(2):92-97. Epub 2020 Dec 4.
Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era.
- Cardiovascular Research Unit
2020 Oct. J Transl Med.18(1):408.
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day mortality in cardiogenic shock.
- Cardiovascular Research Unit
2020 Oct. Int J Mol Sci.21(21).
Transcriptomics research to improve cardiovascular healthcare.
- Cardiovascular Research Unit
2020 Sep. Eur Heart J.41(35):3296-3298.
Non-coding RNAs in the brain-heart axis: The case of Parkinson’s Disease.
- Cardiovascular Research Unit
2020 Sep. Int J Mol Sci.21(18).
Approaching sex differences in cardiovascular non-coding RNA research.
- Cardiovascular Research Unit
2020 Jul. Int J Mol Sci.21(14):E4890.
Circulating levels of brain-enriched microRNAs correlate with neuron specific enolase after cardiac arrest-A substudy of the target temperature management trial.
- Cardiovascular Research Unit
2020 Jun. Int J Mol Sci.21(12).